PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis : a proof-of-concept study
| dc.contributor.author | Bresser, Philppa Lynn | |
| dc.contributor.author | Sathekge, Mike Machaba | |
| dc.contributor.author | Vorster, Mariza | |
| dc.date.accessioned | 2023-07-18T10:16:18Z | |
| dc.date.available | 2023-07-18T10:16:18Z | |
| dc.date.issued | 2022-07 | |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.librarian | hj2023 | en_US |
| dc.description.uri | http://journals.lww.com/nuclearmedicinecomm | en_US |
| dc.identifier.citation | Bresser, P.L., Sathekge, M.M. & Vorster, M. 2022, 'PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study', Nuclear Medicine Communications, vol. 43, no. 7, pp. 787-793, doi : 10.1097/MNM.0000000000001580. | en_US |
| dc.identifier.issn | 0143-3636 (print) | |
| dc.identifier.issn | 1473-5628 (online) | |
| dc.identifier.other | 10.1097/MNM.0000000000001580 | |
| dc.identifier.uri | http://hdl.handle.net/2263/91507 | |
| dc.language.iso | en | en_US |
| dc.publisher | Lippincott, Williams & Wilkins | en_US |
| dc.rights | © 2022 Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form in Nuclear Medicine Communications, vol. 43, no. 7, pp. 787-793, doi : 10.1097/MNM.0000000000001580. | en_US |
| dc.subject | 68Ga-nitroimidazole PET/CT | en_US |
| dc.subject | Hypoxia | en_US |
| dc.subject | Positron emission tomography/computed tomography (PET/CT) | en_US |
| dc.subject | Tuberculosis (TB) | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis : a proof-of-concept study | en_US |
| dc.type | Postprint Article | en_US |